The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer
Abstract
Measurement of human urinary carcinogen metabolites is a practical approach for obtaining important information about tobacco and cancer. This review presents currently available methods and evaluates their utility. Carcinogens and their metabolites and related compounds that have been quantified in the urine of smokers or non-smokers exposed to environmental tobacco smoke (ETS) include trans,trans-muconic acid (tt-MA) and S-phenylmercapturic acid (metabolites of benzene), 1- and 2-naphthol, hydroxyphenanthrenes and phenanthrene dihydrodiols, 1-hydroxypyrene (1-HOP), metabolites of benzo[a]pyrene, aromatic amines and heterocyclic aromatic amines, N-nitrosoproline, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides (NNAL and NNAL-Gluc), 8-oxodeoxyguanosine, thioethers, mercapturic acids, and alkyladenines. Nitrosamines and their metabolites have also been quantified in the urine of smokeless tobacco users. The utility of these assays to provide information about carcinogen dose, delineation of exposed vs. non-exposed individuals, and carcinogen metabolism in humans is discussed. NNAL and NNAL-Gluc are exceptionally useful biomarkers because they are derived from a carcinogen- 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)- that is specific to tobacco products. The NNAL assay has high sensitivity and specificity, which are particularly important for studies on ETS exposure. Other useful assays that have been widely applied involve quantitation of 1-HOP and tt-MA. Urinary carcinogen metabolite biomarkers will be critical components of future studies on tobacco and human cancer, particularly with respect to new tobacco products and strategies for harm reduction, the role of metabolic polymorphisms in cancer, and further evaluation of human carcinogen exposure from ETS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans
Carter, R. L. (1980) · Journal of Clinical Pathology · doi:10.1136/jcp.33.1.98-b · Cited by 3,456
Tobacco Smoke Carcinogens and Lung Cancer
Hecht, S. S. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.14.1194 · Cited by 1,976
Self-citationShepard, T. H. (1981) · Teratology · doi:10.1002/tera.1420230118 · Cited by 1,296
Biochemistry, Biology, and Carcinogenicity of Tobacco-Specific N-Nitrosamines
Hecht, S. S. (1998) · Chemical Research in Toxicology · doi:10.1021/tx980005y · Cited by 1,071
Self-citationCotinine as a Biomarker of Environmental Tobacco Smoke Exposure
Benowitz, N. L. (1996) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017925 · Cited by 1,024
Molecular Biology of Mutagens and Carcinogens
Singer, B., & Grunberger, D. (1983) · Springer eBooks · doi:10.1007/978-1-4613-3772-0 · Cited by 791
The Less Harmful Cigarette: A Controversial Issue. A Tribute to Ernst L. Wynder
Hoffmann, D., Hoffmann, I., & El-Bayoumy, K. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000260u · Cited by 745
Mortality from smoking worldwide
Peto, R., Lopez, A. D., Boreham, J., Thun, M., Heath, C., & Doll, R. (1996) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011519 · Cited by 638
Environment and Cancer: Who Are Susceptible?
Perera, F. P. (1997) · Science · doi:10.1126/science.278.5340.1068 · Cited by 638
Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke
Hecht, S. S., & Hoffmann, D. (1988) · Carcinogenesis · doi:10.1093/carcin/9.6.875 · Cited by 528
Self-citation
Cited by
A review of airborne polycyclic aromatic hydrocarbons (PAHs) and their human health effects
Kim, K.-H., Jahan, S. A., Kabir, E., & Brown, R. J. C. (2013) · Environment International · doi:10.1016/j.envint.2013.07.019 · Cited by 2,420
Tobacco carcinogens, their biomarkers and tobacco-induced cancer
Hecht, S. S. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1190 · Cited by 1,551
Self-citationTobacco and Cancer: Recent Epidemiological Evidence
Vineis, P., Alavanja, M., Buffler, P., Fontham, E., Franceschi, S., Gao, Y. T., Gupta, P. C., Hackshaw, A., Matos, E., Samet, J., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh014 · Cited by 741
LEWTAS, J. (2007) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2007.08.003 · Cited by 685
Environmental and chemical carcinogenesis
Wogan, G. N., Hecht, S. S., Felton, J. S., Conney, A. H., & Loeb, L. A. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.010 · Cited by 656
Self-citationAlkylation damage in DNA and RNA—repair mechanisms and medical significance
Drabløs, F., Feyzi, E., Aas, P. A., Vaagbø, C. B., Kavli, B., Bratlie, M. S., Peña-Diaz, J., Otterlei, M., Slupphaug, G., & Krokan, H. E. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.05.004 · Cited by 648
Goniewicz, M. L., Smith, D. M., Edwards, K. C., Blount, B. C., Caldwell, K. L., Feng, J., Wang, L., Christensen, C., Ambrose, B., Borek, N., et al. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.5937 · Cited by 564
Self-citationPCA as a Practical Indicator of OPLS-DA Model Reliability
Worley, B., & Powers, R. (2016) · Current Metabolomics · doi:10.2174/2213235x04666160613122429 · Cited by 498
Lung carcinogenesis by tobacco smoke
Hecht, S. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27816 · Cited by 480
Self-citationMicronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies
Bonassi, S., El-Zein, R., Bolognesi, C., & Fenech, M. (2011) · Mutagenesis · doi:10.1093/mutage/geq075 · Cited by 471
Lee, H.-W., Park, S.-H., Weng, M.-W., Wang, H.-T., Huang, W. C., Lepor, H., Wu, X.-R., Chen, L.-C., & Tang, M.-S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718185115 · Cited by 343
Turesky, R. J., & Le Marchand, L. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200135s · Cited by 337
Metabolomics in cancer biomarker discovery: Current trends and future perspectives
Armitage, E. G., & Barbas, C. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.08.041 · Cited by 331
Smoking-related DNA and protein adducts in human tissues
Phillips, D. H. (2002) · Carcinogenesis · doi:10.1093/carcin/23.12.1979 · Cited by 294
Progress and Challenges in Selected Areas of Tobacco Carcinogenesis
Hecht, S. S. (2008) · Chemical Research in Toxicology · doi:10.1021/tx7002068 · Cited by 282
Self-citationAssessing secondhand smoke using biological markers
Avila-Tang, E., Al-Delaimy, W. K., Ashley, D. L., Benowitz, N., Bernert, J. T., Kim, S., Samet, J. M., & Hecht, S. S. (2013) · Tobacco Control · doi:10.1136/tobaccocontrol-2011-050298 · Cited by 265
Self-citationCigarette smoking: cancer risks, carcinogens, and mechanisms
Hecht, S. S. (2006) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-006-0111-z · Cited by 256
Self-citationDoes smoking reduction increase future cessation and decrease disease risk? A qualitative review
Hughes, J., & Carpenter, M. (2006) · Nicotine & Tobacco Research · doi:10.1080/14622200600789726 · Cited by 238
Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen
Hecht, S. S., Murphy, S. E., Carmella, S. G., Zimmerman, C. L., Losey, L., Kramarczuk, I., Roe, M. R., Puumala, S. S., Li, Y. S., Le, C., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh016 · Cited by 101
Self-citation
Metadata
- Authors
- Hecht, S. S.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-06
- Volume
- 23
- Issue
- 6
- Pages
- 907-922
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2171924267
- Cited by
- 404
- References
- 118
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.